383 related articles for article (PubMed ID: 33833449)
21. LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models.
Cedó L; Metso J; Santos D; García-León A; Plana N; Sabate-Soler S; Rotllan N; Rivas-Urbina A; Méndez-Lara KA; Tondo M; Girona J; Julve J; Pallarès V; Benitez-Amaro A; Llorente-Cortes V; Pérez A; Gómez-Coronado D; Ruotsalainen AK; Levonen AL; Sanchez-Quesada JL; Masana L; Kovanen PT; Jauhiainen M; Lee-Rueckert M; Blanco-Vaca F; Escolà-Gil JC
Circ Res; 2020 Aug; 127(6):778-792. PubMed ID: 32495699
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol efflux and reverse cholesterol transport.
Favari E; Chroni A; Tietge UJ; Zanotti I; Escolà-Gil JC; Bernini F
Handb Exp Pharmacol; 2015; 224():181-206. PubMed ID: 25522988
[TBL] [Abstract][Full Text] [Related]
23. Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport.
El Khoury P; Waldmann E; Huby T; Gall J; Couvert P; Lacorte JM; Chapman J; Frisdal E; Lesnik P; Parhofer KG; Le Goff W; Guerin M
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):285-94. PubMed ID: 26681758
[TBL] [Abstract][Full Text] [Related]
24. Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport.
Fernández-Suárez ME; Escolà-Gil JC; Pastor O; Dávalos A; Blanco-Vaca F; Lasunción MA; Martínez-Botas J; Gómez-Coronado D
Sci Rep; 2016 Sep; 6():32105. PubMed ID: 27601313
[TBL] [Abstract][Full Text] [Related]
25. Rosuvastatin activates ATP-binding cassette transporter A1-dependent efflux ex vivo and promotes reverse cholesterol transport in macrophage cells in mice fed a high-fat diet.
Shimizu T; Miura S; Tanigawa H; Kuwano T; Zhang B; Uehara Y; Saku K
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2246-53. PubMed ID: 25104799
[TBL] [Abstract][Full Text] [Related]
26. Reverse cholesterol transport and cholesterol efflux in atherosclerosis.
Ohashi R; Mu H; Wang X; Yao Q; Chen C
QJM; 2005 Dec; 98(12):845-56. PubMed ID: 16258026
[TBL] [Abstract][Full Text] [Related]
27. Cholesteryl esters in lymph chylomicrons: contribution from high density lipoprotein transferred from plasma into intestinal lymph.
Oliveira HC; Nilausen K; Meinertz H; Quintão EC
J Lipid Res; 1993 Oct; 34(10):1729-36. PubMed ID: 8245723
[TBL] [Abstract][Full Text] [Related]
28. Cholesterol efflux is defective in macrophages from atherosclerosis-susceptible White Carneau pigeons relative to resistant show racer pigeons.
Yancey PG; St Clair RW
Arterioscler Thromb; 1992 Nov; 12(11):1291-304. PubMed ID: 1420089
[TBL] [Abstract][Full Text] [Related]
29. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
Breevoort SR; Angdisen J; Schulman IG
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
[TBL] [Abstract][Full Text] [Related]
30. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport.
Francone OL; Haghpassand M; Bennett JA; Royer L; McNeish J
J Lipid Res; 1997 Apr; 38(4):813-22. PubMed ID: 9144096
[TBL] [Abstract][Full Text] [Related]
31. [Antiatherogenic effect of high density lipoprotein].
Turczyn B; Skoczyńska A
Postepy Hig Med Dosw; 2002; 56(4):499-520. PubMed ID: 12418415
[TBL] [Abstract][Full Text] [Related]
32. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis.
Rader DJ; Alexander ET; Weibel GL; Billheimer J; Rothblat GH
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S189-94. PubMed ID: 19064999
[TBL] [Abstract][Full Text] [Related]
33. Rate-limiting factors of cholesterol efflux in reverse cholesterol transport: acceptors and donors.
Fu Y
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):703-9. PubMed ID: 20374257
[TBL] [Abstract][Full Text] [Related]
34. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
[TBL] [Abstract][Full Text] [Related]
35. Aerobic exercise improves reverse cholesterol transport in cholesteryl ester transfer protein transgenic mice.
Rocco DD; Okuda LS; Pinto RS; Ferreira FD; Kubo SK; Nakandakare ER; Quintão EC; Catanozi S; Passarelli M
Lipids; 2011 Jul; 46(7):617-25. PubMed ID: 21479674
[TBL] [Abstract][Full Text] [Related]
36. Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data.
Fredenrich A; Bayer P
Diabetes Metab; 2003 Jun; 29(3):201-5. PubMed ID: 12909808
[TBL] [Abstract][Full Text] [Related]
37. Quantification of In Vitro Macrophage Cholesterol Efflux and In Vivo Macrophage-Specific Reverse Cholesterol Transport.
Escolà-Gil JC; Lee-Rueckert M; Santos D; Cedó L; Blanco-Vaca F; Julve J
Methods Mol Biol; 2015; 1339():211-33. PubMed ID: 26445792
[TBL] [Abstract][Full Text] [Related]
38. [HDL and reverse cholesterol transport. Role of cholesterol ester transfer protein].
Lagrost L; Gambert P
C R Seances Soc Biol Fil; 1992; 186(4):405-13. PubMed ID: 1301229
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of stearoyl-coenzyme A desaturase 1 in macrophages promotes reverse cholesterol transport.
Nakaya K; Ayaori M; Uto-Kondo H; Sotherden GM; Nishida T; Katamoto H; Miura Y; Takiguchi S; Yakushiji E; Iizuka M; Ogura M; Sasaki M; Yogo M; Komatsu T; Adachi T; Maruyama C; Ikewaki K
Biochim Biophys Acta; 2013 Aug; 1831(8):1402-11. PubMed ID: 23747827
[TBL] [Abstract][Full Text] [Related]
40. High-density lipoprotein revisited: biological functions and clinical relevance.
von Eckardstein A; Nordestgaard BG; Remaley AT; Catapano AL
Eur Heart J; 2023 Apr; 44(16):1394-1407. PubMed ID: 36337032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
